J. Tuomilehto

Effect of nateglinide on the incidence of diabetes and cardiovascular events.

T. Hua, R. Nesto, H. İlkova, 2010, The New England journal of medicine.

Coffee consumption and risk of total and cardiovascular mortality among patients with type 2 diabetes

J. Tuomilehto, P. Jousilahti, R. Antikainen, 2006, Diabetologia.

A population-specific diabetogenic haplotype HLA-A2,Cw1,B56,DR4,DQ8 is associated with high birthweight in Finnish diabetic families

L. Kinnunen, J. Tuomilehto, V. Harjutsalo, 2008, Genes and Immunity.

Identification of heart rate–associated loci and their effects on cardiac conduction and rhythm disorders

Kathleen F. Kerr, May E. Montasser, M. Jarvelin, 2013, Nature Genetics.

The EUROSTROKE cohorts: a short description and data analytical approach

P. Elwood, D. Grobbee, Y. Nikitin, 2002, Journal of epidemiology and community health.

Markers of cholesterol metabolism as biomarkers in predicting diabetes in the Finnish Diabetes Prevention Study.

J. Eriksson, J. Lindström, P. Ilanne-Parikka, 2015, Nutrition, metabolism, and cardiovascular diseases : NMCD.

Cardiovascular autonomic dysfunction is associated with central obesity in persons with impaired glucose tolerance

J. Eriksson, J. Lindström, P. Ilanne-Parikka, 2011, Diabetic medicine : a journal of the British Diabetic Association.

Finnish case–control and family studies support PTPN22 R620W polymorphism as a risk factor in rheumatoid arthritis, but suggest only minimal or no effect in juvenile idiopathic arthritis

J. Tuomilehto, A. Begovich, H. Alexander, 2005, Genes and Immunity.